Peer-reviewed work

News & publications

This is where you can follow Atlantis Healthcare news and media coverage, plus view our industry publications.

Our publications summarize the challenges of living with a health condition; they also demonstrate how our belief-driven behavior change approach can have an impact across a range of health conditions. All our research is guided by robust protocols to support qualitative and quantitative methodologies.

“It’s like having a friend in your pocket”: Refining CBT-informed digital support for people with autoimmune conditions

“It’s like having a friend in your pocket”: Refining CBT-informed digital support for people with autoimmune conditions

Wednesday, 10 April 2019

Mood disorders are common among patients with autoimmune conditions such as Rheumatoid Arthritis and Crohn’s Disease, and is associated with poor medication adherence and limitations to physical, social, and role functioning. Atlantis Healthcare presented a poster at the 2019 CBC Conference in London demonstrating that using electronic delivery of CBT (eCBT) for sub-clinical low mood may be an effective way to promote adaptive coping for physical and emotional aspects of autoimmune disease management.

Support for patients treated with growth hormone to reach their growth potential: addressing adherence barriers through personalised behavioural patient-support programmes

Support for patients treated with growth hormone to reach their growth potential: addressing adherence barriers through personalised behavioural patient-support programmes

Thursday, 29 November 2018

Recombinant human growth hormone (r-hGH) treatment can optimise growth potential; however, optimum outcomes are not always achieved owing to several reasons, including poor adherence. Atlantis Healthcare co-authored a poster that was presented at the 2018 ESPACOMP conference, identifying key psychosocial factors and interventions to address these barriers through personalised behavioural patient-support programmes.

What drives severe haemophilia patients’ decisions to change treatment?

What drives severe haemophilia patients’ decisions to change treatment?

Friday, 07 September 2018

Haemophilia patients face many challenges when considering the best treatment for them. Atlantis Healthcare presented at the 2018 European Health Psychology Society conference some new insights into haemophilia patient beliefs about treatment, and the influence these have on treatment decision making.

Treatment Adherence in Type 1 Hereditary Tyrosinaemia (HT1)

Treatment Adherence in Type 1 Hereditary Tyrosinaemia (HT1)

Friday, 01 December 2017

A mixed-method nvestigation into the beliefs, attitudes and behaviour of adolescent patients, their families and their healthcare team. This paper explores drivers of adherence in rare disease. 

 Supporting Treatment Adherence in Young People with Tyrosinaemia type 1: Co-Creation Research of a Discussion Guide for Healthcare Professionals

Supporting Treatment Adherence in Young People with Tyrosinaemia type 1: Co-Creation Research of a Discussion Guide for Healthcare Professionals

Thursday, 30 November 2017

Presented at the British Psychological Society Annual Conference 2017, Brighton.   

Displaying results 1-5 (of 14)
 |<  < 1 - 2 - 3  >  >|